GAF Healthcare
Specialty Overview

Best Hospitals for Thyroid Cancer Treatment in Hyderabad, India

4 medical oncology hospitals in our India network are listed in Hyderabad, accredited by JCI, NABH, with 10,076 beds combined.

4
Hospitals Listed
1
City
4.5
Avg. Rating
2
Accreditation Types
The Short Answer

This page lists the medical oncology hospitals in our directory offering Thyroid Cancer Treatment in Hyderabad, India, including KIMS Hospitals, Secunderabad, Yashoda Hospitals, Secunderabad, Apollo Hospital DRDO, Apollo Hospitals, Jubilee Hills. Each listing links through to the hospital's full profile page.

Including:🇮🇳 KIMS Hospitals, Secunderabad🇮🇳 Yashoda Hospitals, Secunderabad🇮🇳 Apollo Hospital DRDO

Ask us about thyroid cancer treatment in Hyderabad, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 4 accredited hospitals for Medical Oncology in Hyderabad, India

KIMS Hospitals, Secunderabad Featured
Starting from$1,000

🇮🇳 KIMS Hospitals, Secunderabad

Hyderabad, India 4.8 (743 reviews) 8,300 beds
Why consider this hospital?
4.8/5 rating from 743 reviewsAccredited by JCI, NABH8,300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsNephrology
Accredited by JCI, NABH

Patients considering thyroid cancer treatment can be cared for by KIMS Hospitals, Secunderabad's care team in Hyderabad, India, from initial consultation through recovery. KIMS Hospitals, Secunderabad, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thyroid cancer treatment.

4.8/5
Rating
2000
Established
8,300
Beds
Hyderabad, India
Location
Enquire NowView Profile
Yashoda Hospitals, Secunderabad
Starting from$1,000

🇮🇳 Yashoda Hospitals, Secunderabad

Secunderabad, Hyderabad, India 4.7 (518 reviews) 1,026 beds
Why consider this hospital?
4.7/5 rating from 518 reviewsAccredited by NABH1,026 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyNeurologyOrthopedicsOncologyGastroenterology
Accredited by NABH

Patients considering thyroid cancer treatment can be cared for by Yashoda Hospitals, Secunderabad's care team in Secunderabad, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Secunderabad, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing thyroid cancer treatment.

4.7/5
Rating
1989
Established
1,026
Beds
Secunderabad, Hyderabad, India
Location
Enquire NowView Profile
Apollo Hospital DRDO
Starting from$1,000

🇮🇳 Apollo Hospital DRDO

Kanchan Bagh, Hyderabad, India 4.5 (82 reviews) 200 beds
Why consider this hospital?
4.5/5 rating from 82 reviewsAccredited by NABH, JCI200 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsOncologyNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering thyroid cancer treatment can be cared for by Apollo Hospital DRDO's care team in Kanchan Bagh, Hyderabad, India, from initial consultation through recovery. Apollo Hospital DRDO, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing thyroid cancer treatment.

4.5/5
Rating
2001
Established
200
Beds
Kanchan Bagh, Hyderabad, India
Location
Enquire NowView Profile
Apollo Hospitals, Jubilee Hills
Starting from$1,000

🇮🇳 Apollo Hospitals, Jubilee Hills

Hyderabad, India 4.1 (44 reviews) 550 beds
Why consider this hospital?
4.1/5 rating from 44 reviewsAccredited by JCI, NABH550 bedsHas a dedicated Medical Oncology department
Specialties & Accreditation
Medical OncologyCardiac SurgeryCardiologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering thyroid cancer treatment can be cared for by Apollo Hospitals, Jubilee Hills's Medical Oncology department in Hyderabad, India, from initial consultation through recovery. Apollo Hospitals, Jubilee Hills, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thyroid cancer treatment.

4.1/5
Rating
1988
Established
550
Beds
Hyderabad, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Medical Oncology is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Thyroid Cancer Treatment in Hyderabad, India?

Choosing the right hospital for thyroid cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include medical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Thyroid Cancer Treatment

Thyroid cancer treatment encompasses a spectrum of curative and disease-modifying interventions—including total thyroidectomy, radioactive iodine (RAI) ablation, targeted molecular therapies, and external beam radiotherapy—tailored to histological subtype and disease staging.

3–7 days (varies by surgical extent and adjuvant therapy requirement)
Hospital Stay
2–4 weeks (longer if post-surgical RAI therapy is incorporated into the protocol)
Total Stay in Country (Fit-to-Fly)
98%+ (differentiated thyroid cancer, early-to-locoregional stage); 70–85% (locally advanced or recurrent disease managed with targeted therapy)
Success Rate

Clinical Overview

  • Thyroid cancer arises from the follicular epithelial cells or parafollicular C-cells of the thyroid gland and is classified into four principal histological subtypes: papillary thyroid carcinoma (PTC, ~85% of cases), follicular thyroid carcinoma (FTC, ~10%), medullary thyroid carcinoma (MTC, ~3%), and anaplastic thyroid carcinoma (ATC, <2%).
  • PTC and FTC are collectively termed differentiated thyroid cancers (DTC) and carry the most favourable prognosis because they retain iodine-uptake capability, making them amenable to RAI ablation.
  • MTC originates from calcitonin-secreting parafollicular cells and is associated with RET proto-oncogene mutations, both germline (in the context of MEN2A and MEN2B syndromes) and somatic.
Full details →

Who is a Candidate?

  • Confirmed thyroid nodule(s) with fine-needle aspiration cytology (FNAC) reported as Bethesda Category V (suspicious for malignancy) or VI (malignant)
  • Histopathologically proven PTC, FTC, Hurthle cell carcinoma, MTC, or ATC on core needle biopsy or post-lobectomy pathology
  • Patients with compressive symptoms: progressive dysphagia, stridor, voice hoarseness, or superior vena cava syndrome from a large thyroid mass
  • MEN2 syndrome carriers or RET mutation-positive individuals (germline testing recommended before prophylactic thyroidectomy)
  • +2 more

Required Diagnostics (pre-treatment work-up):

Full details →

Treatment Options & Approaches

  • Thyroid cancer treatment is subtype-specific and stage-dependent.
  • The following modalities are deployed individually or in multimodal combination:

Recovery

  • PHASE 1 — PRE-ARRIVAL PREPARATION (2–4 weeks before travel)

Risks to be aware of

  • Thyroid cancer surgery and its adjuvant treatments carry a well-characterised but manageable risk profile that patients should discuss openly with their surgeon.
  • Recurrent laryngeal nerve (RLN) injury is the most clinically significant surgical risk, occurring transiently in 5–8% and permanently in 1–2% of total thyroidectomies at high-volume centres; bilateral injury causing airway compromise is rare (<0.5%) but can necessitate tracheostomy.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive non-medical coordination to ensure that international patients experience a seamless, stress-free treatment journey.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Thyroid Cancer Treatment

What is the cost of thyroid cancer treatment in India vs. UAE?
The cost of thyroid cancer treatment varies significantly depending on the histological subtype, surgical scope, and whether adjuvant therapies such as radioactive iodine (RAI) ablation or targeted molecular therapy are required. For a standard total thyroidectomy with central compartment neck dissection, standard medications, and a 4–6-day hospital stay, costs in India range from approximately USD 3,500 to USD 12,000 at JCI- and NABH-accredited centres. The same treatment in the UAE (Dubai or Abu Dhabi) at JCI- and DHA-licensed hospitals typically ranges from USD 9,000 to USD 28,000. India is therefore approximately 55–65% more cost-effective than the UAE for equivalent oncological expertise. When RAI therapy is added, India costs an additional USD 500–2,000 for the procedure, isotope, and radiation safety monitoring, while the UAE adds USD 2,000–6,000. Long-course targeted therapies (e.g., lenvatinib at ~USD 700–1,500/month in India versus USD 2,500–4,000/month in the UAE) are priced and quoted separately per treatment cycle. GAF Healthcare provides a fully itemised cost estimate before any commitment is made.
How long do I need to stay in India or the UAE before I am fit to fly home after thyroid cancer treatment?
If your treatment plan includes surgery alone (total thyroidectomy ± neck dissection) without adjuvant RAI therapy, the minimum recommended stay in the country is 2–3 weeks. This accounts for 4–7 days of in-hospital post-operative recovery, followed by 1–2 weeks of outpatient follow-up to confirm stable serum calcium levels, wound healing, voice recovery assessment, and levothyroxine dose optimisation before international air travel. If your protocol includes post-operative radioactive iodine (RAI / I-131) ablation therapy — which is typically administered 3–4 weeks after surgery to allow TSH levels to rise sufficiently — the total in-country stay extends to 4–6 weeks. This is because (a) the rhTSH (Thyrogen) stimulation protocol or levothyroxine withdrawal period must be completed prior to RAI administration, (b) radiation safety regulations in most countries prohibit air travel for 3–7 days post-RAI administration until radiation levels drop below legally mandated thresholds, and (c) a post-therapy whole-body scan (performed 5–7 days after RAI) must be reviewed before discharge. Patients receiving systemic targeted therapy (e.g., lenvatinib, selpercatinib) as part of their plan can typically travel home after 2–3 weeks once the first cycle's tolerability and initial response parameters have been assessed. Your GAF Healthcare case manager will provide a personalised travel clearance timeline as part of your discharge planning.
What is the success rate of thyroid cancer treatment?
Thyroid cancer has among the most favourable prognoses of all cancers, particularly for the most common subtypes. The 5-year overall survival rate for papillary thyroid carcinoma (PTC) — which accounts for approximately 85% of all thyroid cancers — exceeds 98–99% when detected at Stage I or II (intrathyroidal or with limited nodal involvement), and remains approximately 93% even for Stage III disease with extrathyroidal extension. Follicular thyroid carcinoma (FTC) carries a 5-year survival rate of approximately 91% overall, with Stage I–II disease approaching 98–99%. Medullary thyroid carcinoma (MTC) has a 5-year survival rate of approximately 91% for locoregional disease, falling to approximately 28% in the presence of distant metastases; targeted RET inhibitors (selpercatinib, vandetanib) have significantly improved disease control rates in progressive MTC. Anaplastic thyroid carcinoma (ATC) remains the most aggressive subtype, with a historical median overall survival of 3–6 months; however, BRAF V600E-positive ATC patients treated with dabrafenib plus trametinib now achieve a 1-year overall survival rate of approximately 20–40%, with some patients achieving durable responses. At the JCI-accredited and NABH-accredited partner hospitals within the GAF Healthcare network, high surgical volumes (>150 thyroid cancer surgeries per year at lead centres), intraoperative nerve monitoring, and access to next-generation molecular therapies contribute to outcomes that align with internationally published benchmarks from centres such as Mayo Clinic, MD Anderson, and Memorial Sloan Kettering.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Thyroid Cancer Treatment in Hyderabad, India

Discover the Top Hospitals for Thyroid Cancer Treatment in Hyderabad, India

This page lists 4 accredited medical oncology hospitals in Hyderabad, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about thyroid cancer treatment in Hyderabad, India

How many medical oncology hospitals are listed in Hyderabad, India?
4 hospitals in our Hyderabad, India directory are currently listed for medical oncology including Thyroid Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Medical Oncology is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there medical oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for thyroid cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about thyroid cancer treatment in Hyderabad, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for thyroid cancer treatment in Hyderabad, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us